Hidden heart risk in kids with diabetes: new study investigates
NCT ID NCT07613372
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study examines how common cardiac autonomic neuropathy (nerve damage affecting the heart) is in children and teens with type 1 diabetes. Researchers will monitor 75 participants using heart tests and check if longer diabetes duration or poor blood sugar control raises the risk. The goal is to better understand and detect this complication early.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand and screen for early heart nerve damage in children with type 1 diabetes.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to all children with type 1 diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 75 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Feb 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Age ≤18 years old Both males and females will be included. Patients diagnosed with type 1 DM for a duration ≥ 5 y. Both well controlled and poorly controlled patients will be included. Exclusion Criteria: Patients with diabetes other than Type 1 DM. Coexisting medical conditions such as thyroid disorders, celiac disease, epilepsy, or chronic pulmonary or hepatic disease. Known cardiac conditions, including congenital heart disease, cardiomyopathy, conduction disorders, or previous cardiac surgery. Acute illness at the time of evaluation or history of diabetic ketoacidosis within the preceding 3 months. Use of medications affecting heart rate or rhythm, including beta-blockers, theophylline, or levothyroxine
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac autonomic neuropathy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tanta university
Al Gharbī Bahjūrah, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common vitamin lift depression in young people?
- Can brain tests unlock the social struggles of turner syndrome?
- A simple ventilation tweak might make Kids' anesthesia safer
- Pain lessons for preteens: could a classroom program reshape how children understand and respond to pain?
- Can type 1 diabetes hold kids back from being fit and active? a study aims to find out.
- Hidden nerve damage may disrupt Heart's electrical activity during surgery